Search Result "refametinib"
The Therapeutic Potential of MEK1/2 Inhibitors in the Treatment of Gynecological Cancers: Rational Strategies and Recent Progress
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 6 Year: 2020 Page: 417-428
Author(s): Sadaf Ghanaatgar-Kasbi,Majid Khazaei,Azam Rastgar-Moghadam,Gordon A. Ferns,Seyed Mahdi Hassanian,Amir Avan
Anti-Metastatics: An Overview of Drug Candidates in Current Pipelines
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 42 Year: 2014 Page: 6522-6528
Author(s): Anne Schaap-Nutt,Dane A. Thyssen,David W. Drell,Frank Entschladen
Back to the Bench? MEK and ERK Inhibitors for the Treatment of KRAS Mutant Lung Adenocarcinoma
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 5 Year: 2018 Page: 558-574
Author(s): Jens Kohler,Marco Catalano,Chiara Ambrogio
Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 1 Year: 2021 Page: 3107-3146
Author(s): Tao Wang,Qiting Zhang,Ning Wang,Ziqi Liu,Bin Zhang,Yufen Zhao
The Therapeutic Promise of Anti-Cancer Drugs Against the Ras/Raf/MEK/ERK Pathway
Ebook: Topics in Anti-Cancer Research
Volume: 2 Year: 2013
Author(s): Erin K. Crane,Kwong-Kwok Wong
Doi: 10.2174/9781608051366113020006
Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond
Journal: Clinical Cancer Drugs
Volume: 2 Issue: 2 Year: 2015 Page: 128-137
Author(s): Ping Wang, Xueying Sun
Review and Prospect of Tissue-agnostic Targeted Strategies in Anticancer Therapies
Journal: Current Topics in Medicinal Chemistry
Volume: 21 Issue: 5 Year: 2021 Page: 404-425
Author(s): Yu Peng,Hongxun Tao,Yuanqing Gao,Yuanyuan Yang,Zhiyong Chen
A Comprehensive Review on Targeted Cancer Therapy: New Face ofTreatment Approach
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 41 Year: 2023 Page: 3282-3294
Author(s):